Cancer is a multistep genetic disease with accumulation of mutations in gen
es involved in the regulation of cell proliferation. In lung cancer, mutati
on of genes such are Rbl, p53, myc or ras are found frequently. The p53 tum
or suppressor gene is involved in the regulation of genetic stability after
DNA damage. It has been found that frequency, spectrum and distribution of
p53 mutations in lung cancer are determined by tobacco.
So far, there is no clear cut data concerning the association of p53 mutati
on and either response to therapy or prognosis of the patient. Gene therapy
using viral vectors expressing wild type p53 open new interesting perspect
ive for lung cancer.